These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25313774)

  • 21. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
    Chen ML; Fang CH; Liang LS; Dai LH; Wang XK
    Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II study.
    Bendell JC; Tournigand C; Swieboda-Sadlej A; Barone C; Wainberg ZA; Kim JG; Pericay C; Pastorelli D; Tarazi J; Rosbrook B; Bloom J; Ricart AD; Kim S; Sobrero AF
    Clin Colorectal Cancer; 2013 Dec; 12(4):239-47. PubMed ID: 24188685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of FOLFOX followed by cetuximab for metastatic colorectal cancer with severe liver dysfunction.
    Elsoueidi R; Craig J; Mourad H; Richa EM
    J Natl Compr Canc Netw; 2014 Feb; 12(2):155-60. PubMed ID: 24586077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
    Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
    Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploratory study of hepatic arterial infusion oxaliplatin with systemic 5-fluorouracil/bevacizumab in patients with refractory solid tumor and extensive liver metastases.
    Camacho LH; Garcia S; Panchal AM; Lim J; Hong DS; Ng C; Madoff DC; Fu S; Gayed I; Kurzrock R
    Clin Colorectal Cancer; 2010 Dec; 9(5):311-4. PubMed ID: 21208846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer.
    Goi T; Naruse T; Kimura Y; Fujimoto D; Morikawa M; Koneri K; Yamaguchi A
    World J Surg Oncol; 2015 Oct; 13():296. PubMed ID: 26452624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase 1b dose escalation study of erlotinib in combination with infusional 5-Fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumors.
    Hanauske AR; Cassidy J; Sastre J; Bolling C; Jones RJ; Rakhit A; Fettner S; Brennscheidt U; Feyereislova A; Díaz-Rubio E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):523-31. PubMed ID: 17255274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: role of carcino-embryonic antigen in assessment of response.
    Kern W; Beckert B; Lang N; Waggershauser T; Braess J; Schalhorn A; Hiddemann W
    Anticancer Res; 2000; 20(6D):4973-5. PubMed ID: 11326650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
    Malik Z; Eng C
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatic arterial infusion chemotherapy prior to standard systemic chemotherapy in patients with highly advanced unresectable liver metastases from colorectal cancer: a report of three patients.
    Iguchi T; Idani H; Asami S; Endo H; Inaba Y; Arai Y; Kanazawa S
    Acta Med Okayama; 2011 Feb; 65(1):49-53. PubMed ID: 21339796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluctuation in Plasma 5-Fluorouracil Concentration During Continuous 5-Fluorouracil Infusion for Colorectal Cancer.
    Matsumoto H; Okumura H; Murakami H; Kubota H; Higashida M; Tsuruta A; Tohyama K; Hirai T
    Anticancer Res; 2015 Nov; 35(11):6193-9. PubMed ID: 26504050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastases.
    Wicherts DA; de Haas RJ; Sebagh M; Ciacio O; Lévi F; Paule B; Giacchetti S; Guettier C; Azoulay D; Castaing D; Adam R
    Ann Surg Oncol; 2011 Mar; 18(3):659-69. PubMed ID: 20976564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.
    James MI; Iwuji C; Irving G; Karmokar A; Higgins JA; Griffin-Teal N; Thomas A; Greaves P; Cai H; Patel SR; Morgan B; Dennison A; Metcalfe M; Garcea G; Lloyd DM; Berry DP; Steward WP; Howells LM; Brown K
    Cancer Lett; 2015 Aug; 364(2):135-41. PubMed ID: 25979230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.
    Irving GR; Iwuji CO; Morgan B; Berry DP; Steward WP; Thomas A; Brown K; Howells LM
    Trials; 2015 Mar; 16():110. PubMed ID: 25872567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ambulatory chemotherapy schedule for metastatic colorectal cancer].
    Watine J; Soulage C
    Presse Med; 2001 Jan; 30(1):35. PubMed ID: 11210587
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical pharmacokinetics of oxaliplatin and 5-fluorouracil administered in combination with leucovorin in Korean patients with advanced colorectal cancer.
    Cho HK; Lee ES; Lee JW; Park JK; Kang JH; Lee KS; Shim CK; Chung SJ; Kim DD; Kuh HJ
    J Cancer Res Clin Oncol; 2006 May; 132(5):320-6. PubMed ID: 16395593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications.
    Lentz F; Tran A; Rey E; Pons G; Tréluyer JM
    Am J Pharmacogenomics; 2005; 5(1):21-33. PubMed ID: 15727486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis.
    Takamoto T; Hashimoto T; Sano K; Maruyama Y; Inoue K; Ogata S; Takemura T; Kokudo N; Makuuchi M
    Ann Surg Oncol; 2010 Oct; 17(10):2747-55. PubMed ID: 20425145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic colorectal cancer with severe liver dysfunction successfully treated using FOLFOX therapy.
    Shimura T; Kataoka H; Hirata Y; Mizushima T; Murakami K; Mabuchi M; Mizoshita T; Kubota E; Tanida S; Kamiya T; Joh T
    J Gastrointest Cancer; 2011 Mar; 42(1):68-72. PubMed ID: 20563895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.
    Giacchetti S; Itzhaki M; Gruia G; Adam R; Zidani R; Kunstlinger F; Brienza S; Alafaci E; Bertheault-Cvitkovic F; Jasmin C; Reynes M; Bismuth H; Misset JL; Lévi F
    Ann Oncol; 1999 Jun; 10(6):663-9. PubMed ID: 10442188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.